{"id":"80275daa36f7","type":"article","url":"https://hartvaat.nl/2025/01/01/cholesterolmanagement-bij-vrouwen-heroverwogen-van-risicoschatting-naar-levensla/","title":"Cholesterolmanagement bij vrouwen heroverwogen: van risicoschatting naar levenslange gezondheid","title_en":"Rethinking Cholesterol Management in Women: From Short-Term Risk Estimation to Lifecourse Cardiovascular Health","category":"cholesterol","category_label":"Cholesterol","professions":["apotheker","huisarts","internist"],"tags":["dyslipidemie","ezetimibe","hdl-cholesterol","ldl-cholesterol","lipidenverlaging","niet-statine-therapie","statines"],"journal":"JACC","doi":"https://www.sciencedirect.com/science/article/pii/S0735109726000525?dgcid=rss_sd_all","source_url":"https://doi.org/https://www.sciencedirect.com/science/article/pii/S0735109726000525?dgcid=rss_sd_all","authors":["Michael C. Honigberg"],"significance":7,"published":"2026-03-01","source_date":"2025-01-01","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/","https://hartvaat.nl/kennis/preventie/levenslang-cardiovasculair-risico/"],"congress":"","summary_en":"This JACC perspective advocated rethinking cholesterol management in women by shifting from short-term risk estimation to a lifecourse approach that accounts for pregnancy-related lipid changes, menopause, and sex-specific risk trajectories.","created":"2026-07-03T10:25:46Z","updated":"2026-07-03T13:25:09Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Beschouwing over het heroverdenken van cholesterolmanagement bij vrouwen, met verschuiving van kortetermijnrisicoschatting naar een levenslange benadering van cardiovasculaire gezondheid.","abstract_original":"Publication date: 17 February 2026Source: JACC, Volume 87, Issue 6"}